Table 2. Costs expected with and without vaccination of the first targeted group.

	Expected costs (50–79 at risk)					Total
	1st Year	2nd Year	3rd Year	4th Year	5th Year
Without vaccination program	€11 597 535	€12 252 844	€12 882 597	€13 538 112	€14 196 539	€64 467 625
With vaccination program*	€26 767 386	€2 011 272	€2 111 999	€2 230 071	€2 341 038	€35 461 965

*Includes costs for vaccination program and costs for treatment of pneumococcal CAP cases.